Hip joint disease in psoriatic arthritis: Risk factors and natural history

Annals of the Rheumatic Diseases

Volumn 64, Issue 7, 2005, Pages 1068-1070

  Michet Jr , C J ^a   Mason, T G ^a   Mazlumzadeh, M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COXITIS; DISEASE COURSE; FEMALE; FOLLOW UP; HIP ARTHROPLASTY; HIP DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PELVIS RADIOGRAPHY; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RISK FACTOR; SACROILIITIS; SPONDYLITIS;

ADULT; AGE OF ONSET; ARTHRITIS, PSORIATIC; FOLLOW-UP STUDIES; HIP JOINT; HUMANS; RISK FACTORS; SACROILIAC JOINT; SPONDYLITIS;

EID: 21344471678     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.022228     Document Type: Article

References (17)

1. Amor B, Santos RS, Nahal R, Listrat V, Dougados M. Predictive factors for the longterm outcome of spondyloarthropathies. J Rheumatol 1994;21:1883-7.
2. Carette S, Graham D, Little H, Rubenstein J, Rosen P. The natural disease course of ankylosing spondylitis. Arthritis Rheum 1983;26:186-90.
3. Dwosh IL, Resnick D, Becker MA. Hip involvement in ankylosing spondylitis. Arthritis Rheum 1976;19:683-92.
4. Edmunds L, Elswood J, Kennedy LG, Calin A. Primary ankylosing spondylitis, psoriatic and enteropathic spondyloarthropathy: a controlled analysis. J Rheumatol 1991;18:696-8.
5. Zangger P, Gladman DD, Bogoch ER. Musculoskeletal surgery in psoriatic arthritis. J Rheumatol 1998;25:725-9.
6. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, the European Spondylarthropathy Study Group, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of Spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
7. Calin A, Elswood J. The relationship between pelvic, spinal and hip involvement in ankylosing spandylitis: one disease process or several? [abstract]. Br J Rheumatol 1987;26(suppl 2):116.
8. Marks JS, Hardinge K. Clinical and radiographic features of spandylitic hip disease. Ann Rheum Dis 1979;38:332-6.
9. Shbeeb M, Uramoto KM, Gibson LE, O'Fallon WM, Gabriel SE. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol 2000;27:1247-50.
10. Harvie JN, Lester RS, Little AH. Sacroiliitis in severe psoriasis. Am J Roentgenol 1976;127:579-84.
11. Moller P, Vinje O. Arthropathy and sacro-iliitis in severe psoriasis. Scand J Rheumatol 1980;9:113-17.
12. Hanly JG, Russell ML, Gladman DD. Psoriatic spandyloarthropathy: a long term prospective study. Ann Rheum Dis 1988;47:386-93.
13. Gladman DD, Brubacher B, Buskila D, Langevitz P, Farewell VT. Psoriatic spondyloarthropathy in men and women: a clinical, radiographic, and HLA study. Clin Invest Med 1992;15:371-5.
14. Queiro R, Belzunegui J, Gonzalez C, De DJ, Sarasqueta C, Torre JC, et al. Clinically asymptomatic axial disease in psoriatic spondyloarthropathy: a retrospective study. Clin Rheumatol 2002;21:10-13.
15. Clegg DO, Reda DJ, Abdellatif M. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondyloarthropathies: a Department of Veterans Affairs cooperative study. Arthritis Rheum 1999;42:2325-9.
16. Dougados M, van der Linden S, Leirisalo-Repo M, Huitfeldt B, Juhlin R, Veys E, et al. Sulfasalazine in the treatment of spandyloarthropathy: a randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum 1995;38:618-27.
17. Marzo-Ortega H, Emery P, McGonagle D. The concept of disease modification in spondyloarthropathy. J Rheumatol 2002;29:1583-5.